Six cases of (severe) hypoglycaemia associated with gabapentin use in both diabetic and non-diabetic patients.
Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands.
Joep H G
JH
Scholl
Rike
R
van Eekeren
Eugène P
EP
van Puijenbroek
D000588:Amines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000097:blood*; D000077206:Gabapentin; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000139:chemically induced* / Q000628:therapy; D010146:Pain / Q000097:blood / Q000188:drug therapy*; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D000588:Amines; D000700:Analgesics; D001786:Blood Glucose; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin